Igalmi
Found 1 recent publications
Today, Nov 16
16:50

Business
Teva Wins US Approval for Home Treatment of Agitation in Schizophrenia
Teva secures first-of-its-kind US approval for home use of IGALMI to treat acute agitation in schizophrenia and bipolar patients, lifting company shares by 2.6%.
Showing latest 50 articles for this tag